BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19177549)

  • 1. A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats.
    Chung BD; Kayserili H; Ai M; Freudenberg J; Uzümcü A; Uyguner O; Bartels CF; Höning S; Ramirez A; Hanisch FG; Nürnberg G; Nürnberg P; Warman ML; Wollnik B; Kubisch C; Netzer C
    Hum Mutat; 2009 Apr; 30(4):641-8. PubMed ID: 19177549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene.
    Cheung WM; Jin LY; Smith DK; Cheung PT; Kwan EY; Low L; Kung AW
    Bone; 2006 Sep; 39(3):470-6. PubMed ID: 16679074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased bone density in carriers and patients of an Israeli family with the osteoporosis-pseudoglioma syndrome.
    Lev D; Binson I; Foldes AJ; Watemberg N; Lerman-Sagie T
    Isr Med Assoc J; 2003 Jun; 5(6):419-21. PubMed ID: 12841014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
    Ai M; Heeger S; Bartels CF; Schelling DK;
    Am J Hum Genet; 2005 Nov; 77(5):741-53. PubMed ID: 16252235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes.
    Qin M; Hayashi H; Oshima K; Tahira T; Hayashi K; Kondo H
    Hum Mutat; 2005 Aug; 26(2):104-12. PubMed ID: 15981244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia.
    Saarinen A; Saukkonen T; Kivelä T; Lahtinen U; Laine C; Somer M; Toiviainen-Salo S; Cole WG; Lehesjoki AE; Mäkitie O
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):481-8. PubMed ID: 19673927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling.
    Bhat BM; Allen KM; Liu W; Graham J; Morales A; Anisowicz A; Lam HS; McCauley C; Coleburn V; Cain M; Fortier E; Bhat RA; Bex FJ; Yaworsky PJ
    Gene; 2007 Apr; 391(1-2):103-12. PubMed ID: 17276019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women.
    Ezura Y; Nakajima T; Urano T; Sudo Y; Kajita M; Yoshida H; Suzuki T; Hosoi T; Inoue S; Shiraki M; Emi M
    Bone; 2007 Apr; 40(4):997-1005. PubMed ID: 17306638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.
    Marques-Pinheiro A; Levasseur R; Cormier C; Bonneau J; Boileau C; Varret M; Abifadel M; Allanore Y
    Joint Bone Spine; 2010 Mar; 77(2):151-3. PubMed ID: 20096619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men.
    Crabbe P; Balemans W; Willaert A; van Pottelbergh I; Cleiren E; Coucke PJ; Ai M; Goemaere S; van Hul W; de Paepe A; Kaufman JM
    J Bone Miner Res; 2005 Nov; 20(11):1951-9. PubMed ID: 16234968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.
    Balemans W; Piters E; Cleiren E; Ai M; Van Wesenbeeck L; Warman ML; Van Hul W
    Calcif Tissue Int; 2008 Jun; 82(6):445-53. PubMed ID: 18521528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
    Levasseur R; Lacombe D; de Vernejoul MC
    Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.
    Ai M; Holmen SL; Van Hul W; Williams BO; Warman ML
    Mol Cell Biol; 2005 Jun; 25(12):4946-55. PubMed ID: 15923613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and evolutionary insights into genes encoding proteins with single amino acid repeats.
    Siwach P; Pophaly SD; Ganesh S
    Mol Biol Evol; 2006 Jul; 23(7):1357-69. PubMed ID: 16618963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does lens intrinsic membrane protein MP19 contain a membrane-targeting signal?
    Chen T; Li X; Yang Y; Erdene AG; Church RL
    Mol Vis; 2003 Dec; 9():735-46. PubMed ID: 14735063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.
    Barros ER; Dias da Silva MR; Kunii IS; Lazaretti-Castro M
    J Pediatr Endocrinol Metab; 2008 Aug; 21(8):811-8. PubMed ID: 18825883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Wnt-beta-catenin signaling in bone metabolism].
    Urano T
    Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.
    Narumi S; Numakura C; Shiihara T; Seiwa C; Nozaki Y; Yamagata T; Momoi MY; Watanabe Y; Yoshino M; Matsuishi T; Nishi E; Kawame H; Akahane T; Nishimura G; Emi M; Hasegawa T
    Am J Med Genet A; 2010 Jan; 152A(1):133-40. PubMed ID: 20034086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP.
    Nikopoulos K; Venselaar H; Collin RW; Riveiro-Alvarez R; Boonstra FN; Hooymans JM; Mukhopadhyay A; Shears D; van Bers M; de Wijs IJ; van Essen AJ; Sijmons RH; Tilanus MA; van Nouhuys CE; Ayuso C; Hoefsloot LH; Cremers FP
    Hum Mutat; 2010 Jun; 31(6):656-66. PubMed ID: 20340138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of mutations and genotype-phenotype analysis in Currarino syndrome.
    Köchling J; Karbasiyan M; Reis A
    Eur J Hum Genet; 2001 Aug; 9(8):599-605. PubMed ID: 11528505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.